Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Zynex, Inc.

ZYXINASDAQ
Healthcare
Medical - Distribution
$0.13
$0.07(108.33%)
U.S. Market opens in 15h 57m

Zynex, Inc. Fundamental Analysis

Zynex, Inc. (ZYXI) shows moderate financial fundamentals with a PE ratio of -0.02, profit margin of -68.35%, and ROE of -18.07%. The company generates $0.1B in annual revenue with moderate year-over-year growth of 4.36%.

Key Strengths

Cash Position349.91%
PEG Ratio0.00

Areas of Concern

ROE-18.07%
Operating Margin-62.76%
Current Ratio0.47
We analyze ZYXI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1815.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1815.3/100

We analyze ZYXI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZYXI struggles to generate sufficient returns from assets.

ROA > 10%
-1.63%

Valuation Score

Excellent

ZYXI trades at attractive valuation levels.

PE < 25
-0.02
PEG Ratio < 2
0.00

Growth Score

Weak

ZYXI faces weak or negative growth trends.

Revenue Growth > 5%
4.36%
EPS Growth > 10%
-66.67%

Financial Health Score

Moderate

ZYXI shows balanced financial health with some risks.

Debt/Equity < 1
-1.73
Current Ratio > 1
0.47

Profitability Score

Weak

ZYXI struggles to sustain strong margins.

ROE > 15%
-1807.05%
Net Margin ≥ 15%
-68.35%
Positive Free Cash Flow
No

Key Financial Metrics

Is ZYXI Expensive or Cheap?

P/E Ratio

ZYXI trades at -0.02 times earnings. This suggests potential undervaluation.

-0.02

PEG Ratio

When adjusting for growth, ZYXI's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Zynex, Inc. at -0.04 times its book value. This may indicate undervaluation.

-0.04

EV/EBITDA

Enterprise value stands at 0.88 times EBITDA. This is generally considered low.

0.88

How Well Does ZYXI Make Money?

Net Profit Margin

For every $100 in sales, Zynex, Inc. keeps $-68.35 as profit after all expenses.

-68.35%

Operating Margin

Core operations generate -62.76 in profit for every $100 in revenue, before interest and taxes.

-62.76%

ROE

Management delivers $-18.07 in profit for every $100 of shareholder equity.

-18.07%

ROA

Zynex, Inc. generates $-1.63 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.63%

Following the Money - Real Cash Generation

Operating Cash Flow

Zynex, Inc. generates limited operating cash flow of $-20.62M, signaling weaker underlying cash strength.

$-20.62M

Free Cash Flow

Zynex, Inc. generates weak or negative free cash flow of $-21.05M, restricting financial flexibility.

$-21.05M

FCF Per Share

Each share generates $-0.69 in free cash annually.

$-0.69

FCF Yield

ZYXI converts -11.52% of its market value into free cash.

-11.52%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.02

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.73

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-18.07

vs 25 benchmark

ROA

Return on assets percentage

-1.63

vs 25 benchmark

ROCE

Return on capital employed

2.03

vs 25 benchmark

How ZYXI Stacks Against Its Sector Peers

MetricZYXI ValueSector AveragePerformance
P/E Ratio-0.0228.25 Better (Cheaper)
ROE-1807.05%780.00% Weak
Net Margin-68.35%-20122.00% (disorted) Weak
Debt/Equity-1.730.30 Strong (Low Leverage)
Current Ratio0.474.66 Weak Liquidity
ROA-163.18%-14687.00% (disorted) Weak

ZYXI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Zynex, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

372.57%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-64.76%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

125.47%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ